Table 1.
Exposure | Outcome | No. SNPs | MR method | P | OR | Lower 95% CI limit | Upper 95% CI limit |
---|---|---|---|---|---|---|---|
Omega-6 fatty acids | atopic dermatitis | 51 | IVW | 0.27 | 0.96 | 0.90 | 1.03 |
Weighted median | 0.82 | 1.01 | 0.92 | 1.11 | |||
Weighted mode | 0.66 | 1.03 | 0.91 | 1.16 | |||
MR Egger | 0.80 | 0.98 | 0.85 | 1.13 | |||
Omega-3 fatty acids | 48 | IVW | 0.01 | 0.92 | 0.87 | 0.98 | |
Weighted median | <0.001 | 0.90 | 0.85 | 0.95 | |||
Weighted mode | 0.003 | 0.91 | 0.86 | 0.97 | |||
MR Egger | 0.08 | 0.92 | 0.85 | 1.01 | |||
Polyunsaturated fatty acids | 53 | IVW | 0.08 | 0.94 | 0.87 | 1.01 | |
Weighted median | 0.69 | 0.98 | 0.89 | 1.08 | |||
Weighted mode | 0.67 | 1.03 | 0.91 | 1.16 | |||
MR Egger | 0.89 | 0.99 | 0.86 | 1.14 | |||
Saturated fatty acids | 47 | IVW | 0.25 | 0.95 | 0.87 | 1.04 | |
Weighted median | 0.51 | 1.03 | 0.94 | 1.14 | |||
Weighted mode | 0.56 | 1.03 | 0.93 | 1.15 | |||
MR Egger | 0.45 | 1.06 | 0.91 | 1.23 | |||
Monounsaturated fatty acids | 56 | IVW | 0.37 | 0.96 | 0.88 | 1.05 | |
Weighted median | 0.27 | 0.95 | 0.87 | 1.04 | |||
Weighted mode | 0.84 | 0.99 | 0.90 | 1.09 | |||
MR Egger | 0.87 | 1.01 | 0.88 | 1.17 |